INTERNATIONAL UROLOGICAL SYMPOSIUM MEĐUNARODNI UROLOŠKI SIMPOZIJUM. Leadership in Urology for young urologist and residents, World Wide Meeting
|
|
|
- Gwenda French
- 6 years ago
- Views:
Transcription
1 INTERNATIONAL UROLOGICAL SYMPOSIUM MEĐUNARODNI UROLOŠKI SIMPOZIJUM Leadership in Urology for young urologist and residents, World Wide Meeting Dostignuća u urologiji, smjernice za mlade urologe i specijalizante urologije Final Programme/ Finalni program December / Decembar :00-9:00 Registration / Registracija 09:00-9:30 Opening ceremony / Ceremonija otvaranja Acad. Prof., PhD, Dželaludin Junuzović President of Urologist Association of Federation of B&H Predsjednik udruženja urologa Federacije Bosne i Hercegovine Assoc. Prof., PhD, FEBU, Emre Huri President of IYUA Predsjednik IYUA MD, MSc, Senad Bajramović Member of IYUA board Član odbora IYUA 09:30-09:45 State Of The Art Lecture-Andrology Erectile Dysfunction / Erektilna disfunkcija Dželaludin Junuzović (B&H)
2 09:45-10:05 A life without Erectile Dysfunction fact, fiction or reality?/ Život bez erektilne disfunkcije činjenica, fantazija ili realnost? Eli Lilly- Mini Symposium, Cristian Iulius Surcel (RO) 10:05-10:25 Relationship Between Endothelial Function And Erectile Dysfunction / Veza Između Endotelijalne Funkcije I Erektilne Disfunkcije Dejan Đorđević (SRB) 10:25-10:45 Risk Prostate Cancer - Pro et Contra / Rizik Za Karcinom Prostate: Za i Protiv Otas Durutović (SRB) 10:45-11:05 Management Of Low Risk Prostate Cancer / Tretman Niskorizičnog Karcinoma Prostate Stéfanne Larre (FR) 11:05-11:25 Surgery In High Risk Pca / Hirurgija Visokorizičnog karcinoma prostate Cristian Iulius Surcel (RO) 11:25-11:45 What You Should Know On Neurovascular Bundles Anatomy To Perform Nerve Sparing Prostatectomy? / Šta Je Potrebno Poznavati O Anatomiji Neurovaskularnog Bundla U Cilju Izvođenja Nervnopoštedne Prostatektomije? Emre Huri (TR) 11:45-12:00 Coffe Break/Kafe Pauza 12:00-12:20 Comparison Of Open, Laparoscopic And Robotic Approaches On Oncological And Functional Results / Komparacija Otvorenog, Laparoskopskog I Robotskog Pristupa Na Onkološki I Funkcionalni Rezultat Murat Binbay (TR)
3 12:20-12:40 Discrepancies Between Prostate Needle Biopsy Gleason Gradus, Radical Prostatectomy Gleason Gradus And Expected Pathological Stage: Possible Role Of Prostate Needle Biopsy Technique / Razlika Između Biopsijskog Gleason Gradusa i Konačnog Gleason Gradusa Nakon Radikalne Prostatektomije i Očekivanog Stadija: Moguća Uloga Tehnike Biopsije Prostate Zoran Krstanoski (SLO) 12:40-13:00 Start To Cryotherapy For Prostate Cancer: Is It feasible? / Započnite Krioterapiju Karcinoma Prostate: Da Li Je Izvodljiva? Emre Huri (TR) 13:00-13:20 State Of The Art Lecture-Stone Disease Is SWL Extinct In The Era Of Flexible URS? / Da Li SWL Gubi Smisao U Doba Fleksibilne URS? 13:30-14:30 Lunch / Ručak Ahmet Yaser Müslümanoğlu (TR) Restaurant News 14:30-14:50 When To Start Hormonal Treatment After PSA Relapse Following RP? / Kada Započeti Hormonalni Tretman Nakon PSA Relapsa Poslije Radikalne Prostatektomije? Stéfanne Larre (FR) 14:50-15:10 State Of The Art Lecture-Andrology Andropause / Andropauza Savo Mičić (SRB) 15:10-15:30 New Treatment Options For Castration-Resistant Prostate Cancer / Nove Terapijske Opcije Za Kastraciono Rezistentni Karcinom Prostate Jasmin Bektić (AT)
4 15:30-15:45 Coffe Break / Kafe Pauza 15:45-16:05 Urethral strictures / Strikture uretre Benjamin Kulovac (B&H) 16:05-16:25 Fixed Lymph Nodes In Penile Cancer / Fiksirani Limfni Čvorovi Kod Karcinoma Penisa Cristian Iulius Surcel (RO) 16:25-16:45 Impact Of Medical Therapy For Symptomatic BPH On TURP / Uticaj Medikamentozne Terapije Za Simptomatski BPH na TURP Saša Argirović (SRB) 16:45-17:05 The Role Of PSA Isoforms In The Management Of Prostate Cancer / Uloga PSA Izoformi U Tretmanu Karcinoma Prostate Jasmin Bektić (AT) 17:05-17:35 Guidelines for the treatment of LUTS in men including benign prostatic obstruction (BPO) / Smjernice za tretman simptoma donjeg urinarnog trakta kod muškaraca, uključujući benignu opstrukciju prostate (BPO) Satellite Symposium / Satelitski Simpozijum GlaxoSmithKline-generalni sponzor Milan Žigić, Davor Tomić (B&H) 20:00 Dinner / Večera
5 December / Decembar :00:10:10 Sabalis serrulatae in the treatment of benign prostatic hyperplasia / Sabalis serrulatae u terapiji benigne hiperplazije prostate Berlin-Chemie, Dženan Lepara (B&H) 10:10-10:30 Varicocelae And Infertility, When To Treat And How To Treat? / Varikokela I Sterilitet, Kada Tretirati I Kako? Hajrudin Spahović (B&H) 10:30-10:50 Transurethral Incision Of The Prostate (TUIP): Early And Long-Term Results / Transuretralna Incizija Prostate (TUIP): Rani I Dugoročni Rezultati Saša Argirović (SRB) 10:50-11:10 Female Urology: What Urologist Should Know? / Ženska Urologija: Šta Urolozi Trebaju Znati? Senad Bajramović (B&H) 11:10-11:30 Risc Factors Of Recurrence And Progression In Non-Muscle-Invasive Bladder Cancer After Transurethral Resection / Riziko Faktori Recidiva I Progresije Kod Mišićno- Neinvazivnih Karcinoma Mokraćnog Mjehura Nakon Transuretralne Resekcije Haris Đug (B&H) 11:30-11:50 Zaključak sastanka Urologa BiH / Meeting of Urologist Association of B&H 11:50-12:00 Closing remarks / Završna riječ 12:00 Lunch / Ručak
Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablative therapies, transurethral needle ablation, Adverse events, sexual side effects of BPH Aging, and incidence of BPH associated with
Asian Urology Residency Course 2017 (AURC 2017)
Organizers: Asian Urology Residency Course 2017 (AURC 2017) Urological Association of Asia, American Urological Association, Hong Kong Urological Association and The Chinese University of Hong Kong in
Saturday, 13 February 2016
Saturday, 13 February 2016 16.10 16.15 Opening and welcome C.R. Chapple, Sheffield (GB) 16.15 18.00 What is new in urology 1 Chairs: C. R. Chapple, Sheffield (GB) 16.15 16.35 Functional urology C. Gratzke,
Prostate Overview Quiz
Prostate Overview Quiz 1. The path report reads: Gleason 3 + 4 = 7. The Gleason s score is a. 3 b. 4 c. 7 d. None of the above 2. The path report reads: Moderately differentiated adenocarcinoma of the
Goals & Objectives by Year in Training: U-1
Goals & Objectives by Year in Training: U-1 U-1 (PGY-2, 3) Resident Responsibilities, Goals and Objectives In addition to the goals listed for PGY-1, the U-1 resident will add to his/her knowledge base
Chapter 18: Glossary
Chapter 18: Glossary Sutter Health Cancer Service Line: Prostate Committee Advanced cancer: When the cancer has spread to other parts of the body (including lymph nodes, bones, or other organs) and is
6 TH INTERNATIONAL TECHNO-UROLOGY MEETING (TUM) NEW TECHNOLOGIES FOR A MORE PRECISE SURGERY
Azienda Sanitaria Ospedaliera S.Luigi Gonzaga Orbassano (To) Department of Urology, San Luigi Gonzaga Hospital School of Medicine - University of Torino, Orbassano, Torino, Italy Chairmen: Prof. Francesco
NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A
NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A I OSNOVNI PODACI Ime Dželaludin Prezime Junuzović Godina rođenja 1955 Mjesto rođenja Sarajevo Država Bosna i Hercegovina Zvanje prof.
da Vinci Prostatectomy My Greek personal experience
da Vinci Prostatectomy My Greek personal experience Vassilis Poulakis MD, PhD, FEBU Ass. Prof. of Urology Director of Urologic Clinic Doctors Hospital Athens Laparoscopy - golden standard in Urology -
Asian Urology Residents' Course 2018 Program
Date Day 1 Asian Perspective (Lectures & Presentations) Time (hrs) Index Topic Presenter 0800 0830 Registration 0830 0845 0845-1700 Welcome Address(s) and ming: UAA PRESIDENT ASU DIRECTOR JUA PRESIDENT
GENERAL GOALS & OBJECTIVES U-1. U-1 (PGY-2, 3) GENERAL GOALS and OBJECTIVES
GENERAL GOALS & OBJECTIVES U-1 U-1 (PGY-2, 3) GENERAL GOALS and OBJECTIVES In addition to the goals listed for PGY-1, the U-1 resident will add to his/her knowledge base by participating actively in conferences,
Department of Urology, Cochin hospital Paris Descartes University
Technical advances in the treatment of localized prostate cancer Pr Michaël Peyromaure Department of Urology, Cochin hospital Paris Descartes University Introduction Curative treatments of localized prostate
Laparoscopic Surgery. The Da Vinci Robot. Limits of Laparoscopy. What Robotics Offers. Robotic Urologic Surgery: A New Era in Patient Care
Laparoscopic Surgery Robotic Urologic Surgery: A New Era in Patient Care Laparoscopic technique was introduced in urologic surgery in the 1990s Benefits: Improved recovery time, decreased morbidity Matthew
Prostatectomy as salvage therapy. Cases. Paul Cathcart - Guy s & St Thomas NHS Trust, London
Prostatectomy as salvage therapy Cases Paul Cathcart - Guy s & St Thomas NHS Trust, London Attributes of brachytherapy appeal to young men who place high utility on genitourinary function At risk of
David Gillatt Bristol Urological Institute. David Gillatt Bristol UK
David Gillatt Bristol Urological Institute David Gillatt Bristol UK Prostate Problems The prostate grows with age - >80% men over 60 have benign enlargement As it grows it can obstruct the flow of urine
Benign Prostatic Hyperplasia (BPH)
Benign Prostatic Hyperplasia (BPH) Definition Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH), prostate gland enlargement can cause bothersome
Prostate Cancer. David Wilkinson MD Gulfshore Urology
Prostate Cancer David Wilkinson MD Gulfshore Urology What is the Prostate? Male Sexual Gland Adds nutrients and fluids for sperm This fluid is added to sperm during ejaculation Urethra (urine channel)
Mayo Clinic Update in Urology 2017: February 20-24, 2017 Atlantis, Paradise Island Bahamas
Monday, February 20, 2017 7:00 a.m. Registration 7:00 Continental Breakfast 7:45 Introduction/Pretest 8:00 PSA Screening Update: Who, What, When, Where Julio C. Gundian, Jr., M.D. 8:20 MRI Prostate: Imaging
PRACTICAL Urology. USC Institute of Urology 4 th Annual Conference: Guest Faculty. Thursday January 31, January 31, February 1 2, 2019
USC Institute of Urology 4 th Annual Conference: PRACTICAL Urology January 31, February 1 2, 2019 Guest Faculty Jeffrey Cadeddu, MD University of Texas Southwestern University of Michigan University of
State-of-the-art: vision on the future. Urology
State-of-the-art: vision on the future Urology Francesco Montorsi MD FRCS Professor and Chairman Department of Urology San Raffaele Hospital Vita-Salute San Raffaele University Milan, Italy Disclosures
If you have aggressive cancer, you would want treatment in time for a cure.
Prostate cancer: PSA screening, biopsy, new technologies The treatment/cure should never be worse than the disease. If you have aggressive cancer, you would want treatment in time for a cure. What is PSA?
Urologic Oncology Section
in Gynecologic and Oncology 08:00 09:00 Registration Day 1 27 April, 2017 Thursday 09:00 09:15 Welcome Oleg Sukonko, Edward Trimble 09:15 12:00 Live surgery 1 Laparoscopiс Radical Prostatectomy 13:00 15:00
RECURRENCE OF PROSTATE CANCER AFTER ROBOTIC SURGERY EBOOK
02 April, 2018 RECURRENCE OF PROSTATE CANCER AFTER ROBOTIC SURGERY EBOOK Document Filetype: PDF 501.52 KB 0 RECURRENCE OF PROSTATE CANCER AFTER ROBOTIC SURGERY EBOOK If you have been diagnosed with prostate
2011 PROSTATE BRACHYTHERAPY STUDY
20 PROSTATE BRACHYTHERAPY STUDY CRITERIA Patients receiving prostate brachytherapy at Cox from 2002-200. In this study, we will look at patients with the following prognostic features: PSA
Shift your surgical ambition to surgical action
Dates: February 1-3, 2018 3th International Meeting ENDO-Dubai : Updates in Minimal Invasive surgery in Gynecology Shift your surgical ambition to surgical action AGENDA AT A GLANCE Thursday, February
Non-QPP Measures. # Measure Title Definition Type Domain. Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys
Non-QPP Measures # Measure Title Definition Type Domain 1 Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys Percentage of patients (boys) =< 18 years of age newly diagnosed with undescended
EAU GUIDELINES POCKET EDITION 3
EAU GUIDELINES POCKET EDITION 3 CONTENTS: BENIGN PROSTATIC HYPERPLASIA URINARY INCONTINENCE UROLITHIASIS 2 3 EAU POCKET GUIDELINES POCKET EDITION 3 This is one of a series of convenient pocket size books
creatinine lab order placed abdomen, MRI abdomen, ultrasound abdomen ordered or performed
Non-QPP Measures # Measure Title Definition Type Domain 1 Cryptorchidism: Inappropriate use of scrotal/groin ultrasound on boys Percentage of patients (boys) =< 18 years of age newly diagnosed with undescended
Hong Kong College of Surgical Nursing
Hong Kong College of Surgical Nursing Higher Surgical Nursing Training: Part B Specialty - Urological Nursing Curriculum TABLE OF CONTENTS No. Contents Page. Introduction. Aims. Learning Objectives 4.
Benign Prostatic Hyperplasia (BPH):
Benign Prostatic Hyperplasia (BPH): Evidence Based Guidelines for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the pathophysiology and prevalence of BPH 2. Select the appropriate
When to worry, when to test?
Focus on CME at the University of Calgary Prostate Cancer: When to worry, when to test? Bryan J. Donnelly, MSc, MCh, FRCSI, FRCSC Presented at a Canadian College of Family Practitioner s conference (October
What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen).
What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen). It is a very common cancer in men; some cancers grow very slowly,
Outcomes of Radical Prostatectomy in Thai Men with Prostate Cancer
Original Article Outcomes of Radical Prostatectomy in Thai Men with Prostate Cancer Sunai Leewansangtong, Suchai Soontrapa, Chaiyong Nualyong, Sittiporn Srinualnad, Tawatchai Taweemonkongsap and Teerapon
Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014
Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia Iain McAuley September 15, 2014 Overview Review of the most recent guidelines for ED and BPH ED Guidelines CUA 2006 AUA 2011
Treating BPH: Comparing Rezum UroLift and HoLEP
Treating BPH: Comparing Rezum UroLift and HoLEP Scott M. Cheney MD Mayo Clinic Arizona 2018 MFMER slide-1 Welcome to AZ 2018 MFMER slide-2 Outline Background on BPH, Rezum, Urolift, HoLEP AUA Guideline
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Medical technology guidance SCOPE The UroLift system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia 1
Percentage of patients who underwent endoscopic procedures following SWL
Non-QPP Measures Measure ID Measure Title Definition Type Domain 1 AQUA12 Benign Prostate Hyperplasia: IPSS improvement after diagnosis Percentage of patients with NEW diagnosis of clinically significant
Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano
Dipartimento di Urologia Direttore Prof. Giorgio Guazzoni Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano alberto.saita@humanitas.it
PROGRAMME DRAFT. September 18 th to 20 th 2008
PROGRAMME DRAFT International Advanced Symposium Laparoscopic Treatment of Urological Pelvic Cancers : Course Directors C.C. Abbou Belgium September 18 th to 20 th 2008 Faculty W. Artibani X. Cathelineau
Prostate Cancer Case Study 1. Medical Student Case-Based Learning
Prostate Cancer Case Study 1 Medical Student Case-Based Learning The Case of Mr. Powers Prostatic Nodule The effervescent Mr. Powers is found by his primary care provider to have a prostatic nodule. You
GUIDELINES ON PROSTATE CANCER
10 G. Aus (chairman), C. Abbou, M. Bolla, A. Heidenreich, H-P. Schmid, H. van Poppel, J. Wolff, F. Zattoni Eur Urol 2001;40:97-101 Introduction Cancer of the prostate is now recognized as one of the principal
Prostate artery embolization (PAE) for benign prostatic enlargement (BPE) 1
Prostate artery embolization (PAE) for benign prostatic enlargement (BPE) 1 Somani B K 1, Hacking N 2, Bryant T 2, Coyne J 2, Flowers D 2, Harris M 1, Dyer J 1. Department of Urology 1 and Interventional
AQUA Registry 2019 Non-QPP Measure Specifications. Denominator Exceptions. IPSS<8 None None Yes Patient Reported Outcome (PRO)
AQUA12 Benign Prostate Hyperplasia: IPSS improvement after diagnosis with NEW diagnosis of clinically significant BPH who had IPSS (international prostate symptoms score) or AUASS (American urological
Prostate Cancer Dashboard
Process Risk Assessment Risk assessment: family history assessment of family history of prostate cancer Best Observed: 97 %1 ; Ideal Benchmark:100% measure P8 2 Process Appropriateness of Care Pre-treatment
General information about prostate cancer
Prostate Cancer General information about prostate cancer Key points Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate. Signs of prostate cancer include
da Vinci Prostatectomy
da Vinci Prostatectomy Justin T. Lee MD Director of Robotic Surgery Urology Associates of North Texas (UANT) USMD Prostate Cancer Center (www.usmdpcc.com) Prostate Cancer Facts Prostate cancer Leading
RESIDENCY TRAINING PROGRAMME IN UROLOGY CERTIFICATION APPLICATION FORM PARTICIPATING INSTITUTE(S)
Date application Name primary institute RESIDENCY TRAINING PROGRAMME IN UROLOGY CERTIFICATION APPLICATION FORM Name affiliated institute(s) Name Programme Director PARTICIPATING INSTITUTE(S) This form
BLK Centre for Renal Sciences & Kidney Transplant
24-Hour Helpline: 011-30403040 BLK Super Speciality Hospital Pusa Road, New Delhi - 110005 (India). www.blkhospital.com BLK Centre for Renal Sciences & Kidney Transplant Introduction The BLK Renal Sciences
How do I control (monitor) patients receiving TRT after prostate cancer treatment
How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and John Hansen Chair in Men s Health Research Division of Urology, Department of Surgery
GUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (BPO)
GUIDELINES ON NON-NEUROGENIC MLE LUTS INCLUDING BENIGN PROSTTIC OBSTRUCTION (BPO) (Text update pril 2014) S. Gravas (chair),. Bachmann,. Descazeaud, M. Drake, C. Gratzke, S. Madersbacher, C. Mamoulakis,
THE HISTORY AND EVOLUTION OF PROSTATE CANCER DIAGNOSIS AND TREATMENT BY: DR. ANDREW GROLLMAN ALBUQUERQUE UROLOGY ASSOCIATES
THE HISTORY AND EVOLUTION OF PROSTATE CANCER DIAGNOSIS AND TREATMENT BY: DR. ANDREW GROLLMAN ALBUQUERQUE UROLOGY ASSOCIATES OVERVIEW Diagnosis Laboratory Tests PSA Free and Total PSA PCA-3 4K Score The
RALP Registration Form (new registration)
RALP Registration Form (new registration) RALP registration form new registration v2.0 1 RALP registration form new registration All fields are required, except those marked with an asterisk (*) Variables
All about the Prostate
MEN S HEALTH Dr Nick Pendleton January 16 th 2018 All about the Prostate 1 What does it do? Functions of the Prostate 1. Secretes Prostatic Fluid slightly alkaline fluid, 30% of volume of seminal fluid,
MODULE 3: BENIGN PROSTATIC HYPERTROPHY
MODULE 3: BENIGN PROSTATIC HYPERTROPHY KEYWORDS: Prostatic hypertrophy, prostatic hyperplasia, PSA, voiding dysfunction, lower urinary tract symptoms (LUTS) At the end of this clerkship, the medical student
Society of Academic Urologists AUA Office of Education Report January 21, Victor Nitti, MD Chair, Office of Education
Society of Academic Urologists AUA Office of Education Report January 21, 2017 Victor Nitti, MD Chair, Office of Education AUA Office of Education Supporting Your Residents What can we offer in 2017 to
PSA is rising: What to do? After curative intended radiotherapy: More local options?
Klinik und Poliklinik für Urologie und Kinderurologie Direktor: Prof. Dr. H. Riedmiller PSA is rising: What to do? After curative intended radiotherapy: More local options? Klinische und molekulare Charakterisierung
[PDF] ALTERNATIVES TO LUPRON FOR PROSTATE CANCER EBOOK
![[PDF] ALTERNATIVES TO LUPRON FOR PROSTATE CANCER EBOOK](/thumbs/82/85358853.jpg "[PDF] ALTERNATIVES TO LUPRON FOR PROSTATE CANCER EBOOK")
06 March, 2018 [PDF] ALTERNATIVES TO LUPRON FOR PROSTATE CANCER EBOOK Document Filetype: PDF 506.4 KB 0 [PDF] ALTERNATIVES TO LUPRON FOR PROSTATE CANCER EBOOK See information on benefits and safety. We
Prostate Case Scenario 1
Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has
The state of prostate cancer management and therapies, courtesy of Sperling Prostate Center in Florida
The state of prostate cancer management and therapies, courtesy of Sperling Prostate Center in Florida 1 QUALITY OF LIFE WITH AN AGING PROSTATE: THE PROTOCOL Dan Sperling, MD, DABR Medical Director The
Incision & Radiation-Free Surgery Real-Time MR Guided Ultrasound Therapies. CORPORATE PRESENTATION February 2019
Incision & Radiation-Free Surgery Real-Time MR Guided Ultrasound Therapies CORPORATE PRESENTATION February 2019 2019 PROFOUND MEDICAL CORP. TSX: PRN OTCQX: PRFMF Combining Two Powerful Modalities real
Prostate Cancer Treatment Decision Information Background
Prostate Cancer Treatment Decision Information Background A group of Radiotherapy Clinics of Georgia (RCOG) prostate cancer (PCa) patients developed this web site, in part, based on a slide presentation
FEBRUARY 4 6, Aresty Auditorium, USC Health Science Campus PROSTATE CANCER
Aresty Auditorium, USC Health Science Campus Day ONE: THURSDAY February 4 6:30 7:00 AM Registration - INDUSTRY BREAKFAST PROSTATE CANCER 7:00 AM WELCOME: Inderbir Gill, MD, Chairman, USC Institute of Urology
PROSTATE CANCER. Mr. Jawad Islam. Consultant Urologist. MBBS, MSc, FRCS(Ed), FEBU, FRCS(Urology) People Centred Positive Compassion Excellence
PROSTATE CANCER Mr. Jawad Islam MBBS, MSc, FRCS(Ed), FEBU, FRCS(Urology) Consultant Urologist Where is prostate located and what is its function? What is prostate cancer? How common is prostate cancer?
UROLOGY SERVICES. Knowledge-Powered Medicine upgdocs.org/urology
UROLOGY SERVICES Expert urological treatment with an emphasis on innovative technology and one-on-one patient care Knowledge-Powered Medicine upgdocs.org/urology UROLOGY SERVICES UPG Urology Services provides
A schematic of the rectal probe in contact with the prostate is show in this diagram.
Hello. My name is William Osai. I am a nurse practitioner in the GU Medical Oncology Department at The University of Texas MD Anderson Cancer Center in Houston. Today s presentation is Part 2 of the Overview
The European Board of Urology
Page 1 of 15 The European Board of Urology Sub-specialty certification application: Prostate cancer, A - General information A1 - APPLICATION IDENTIFICATION 1a. Application code blank 1b. EBU internal
44 th Annual Northern California Urological Resident Seminar
44 th Annual Northern California Urological Resident Seminar Saturday April 21, 2018 Top of the Bay Hilton Garden Inn 1800 Powell Street Emeryville, California 94608 Hosted by Department of Urology 44
EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION
EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (Limited text update March 2016) S. Gravas (Chair), T. Bach, A. Bachmann, M. Drake, M. Gacci, C. Gratzke, S. Madersbacher,
S Crouzet, O Rouvière, JY Chapelon, F Mege, X martin, A Gelet
S Crouzet, O Rouvière, JY Chapelon, F Mege, X martin, A Gelet Why HIFU? Efficacy demonstrated Real time control of the target Early control of the necrosis area is possible with MRI or TRUS using contrast
Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, of prostate, holmium laser, 485 495 African prune tree (Pygeum africanum), 454 455 Alfuzosin, 445 446 Alpha-adrenergic agonists,
CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION
Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 1/22/2011 Radiology Quiz of the Week # 4 Page 1 CLINICAL PRESENTATION AND RADIOLOGY QUIZ
Consensus Meeting for Asian-Pacific BPH Guideline
Consensus Meeting for Asian-Pacific BPH Guideline Byung Ha Chung Yonsei University Health System S a t e l l i t e S y m p o s i u m I Contents Diagnosis and Treatment Guidelines for BPH Prostate Volume
BPH with persistently elevated PSA 아주대학교김선일
BPH with persistently elevated PSA 아주대학교김선일 PSA in BPH: present status AUA & EAU BPH guideline: PSA: recommended test AUA practice guideline committee. J Urol 2003;170:530 Madersbacher. Eur Urol 2004;46:547
Quality of Life with an Aging Prostate: The Sperling Prostate Center Protocol. Dan Sperling, MD, DABR The Sperling Prostate Center Delray Beach, FL
Quality of Life with an Aging Prostate: The Sperling Prostate Center Protocol Dan Sperling, MD, DABR The Sperling Prostate Center Delray Beach, FL As men age, physiological changes affect QOL Testosterone
Controversy Surrounds Question of Who Needs to be Treated for Prostate Cancer No One Size Fits All Diagnosis or Treatment
For Immediate Release Media Contact: Nancy Sergeant, Sergeant Marketing, 973-334-6666, nsergeant@sergeantmarketing.com Mary Appelmann, Sergeant Marketing, 973-263-6392, mappelmann@sergeantmarketing.com
Appendix 4 Urology Care Pathways
Appendix 4 Urology Care Pathways Cancer Care Pathways outline the steps and stages in the patient journey from referral through to diagnostics, staging, treatment, follow up, rehabilitation and if applicable
Prostate Cancer: from Beginning to End
Prostate Cancer: from Beginning to End Matthew D. Katz, M.D. Assistant Professor Urologic Oncology Robotic and Laparoscopic Surgery University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer
Programme. Day -2 5 th August 2019 Monday. Day -1 6 th August 2019 Tuesday. Day 0 7 th August 2019 Wednesday
Day -2 5 th August 2019 Monday *Disclaimer: is subject to change 08:30 Asian Urology Resident s Course (AURC) 08:30-17:00 Day -1 6 th August 2019 Tuesday 08:30 Asian Urology Resident s Course (AURC) 08:30-17:00
PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA
St. Louis Hospital PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA INITIAL CLINICAL RESULTS Faculty of Medical Sciences New University of Lisbon JOÃO PISCO LUÍS CAMPOS PINHEIRO TIAGO BILHIM HUGO RIO TINTO
Friday 25 May EAU Lecture Where are we in male infertility in 2018? J.O.R. Sonksen, Herlev (DK)
Friday 25 May 2018 08.45 09.00 Welcome M. Jievaltas, Kaunas (LT) A. Kotsar, Tartu (EE) A. Strotsky, Minsk (BY) C.R. Chapple, Sheffield (GB) 09.00 09.30 EAU Lecture Where are we in male infertility in 2018?
The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon
Prostate case study Presented by Mr Alan Thompson Consultant Urological Surgeon 2 Part one Initial presentation A 62 year old male solicitor attends your GP surgery. He has rarely seen you over the last
Comparative Analysis Research of Robotic Assisted Laparoscopic Prostatectomy
Comparative Analysis Research of Robotic Assisted Laparoscopic Prostatectomy By: Jonathan Barlaan; Huy Nguyen Mentor: Julio Powsang, MD Reader: Richard Wilder, MD May 2, 211 Abstract Introduction: The
PROSTATE CANCER: A Primer of Diagnosis and Treatment. Jay C. Lee, MD, FRCSC Clinical Associate Professor University of Calgary
PROSTATE CANCER: A Primer of Diagnosis and Treatment Jay C. Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document
Open clinical uro-oncology trials in Canada
Open clinical uro-oncology trials in Canada Eric Winquist, MD, George Rodrigues, MD London Health Sciences Centre, London, Ontario, Canada bladder cancer A PHASE II PROTOCOL FOR PATIENTS WITH STAGE T1
EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION
EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (Text update March 2017) S. Gravas (Chair), T. Bach, M. Drake, M. Gacci, C. Gratzke, T.R.W. Herrmann, S. Madersbacher,
Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017
Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017 Dr Puay Hoon Tan Division of Pathology Singapore General Hospital Prostate cancer (acinar adenocarcinoma) Invasive carcinoma composed
20 Prostate Cancer Dan Ash
20 Prostate Cancer Dan Ash 1 Introduction Prostate cancer is a disease of ageing men for which the aetiology remains unknown. The incidence rises up to 30 to 40% in men over 80. The symptoms of localised
Definition Prostate cancer
Prostate cancer 61 Definition Prostate cancer is a malignant neoplasm that arises from the prostate gland and the most common form of cancer in men. localized prostate cancer is curable by surgery or radiation
HOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION.
IN YOUR HANDS HOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION. Main Application Fields UROLOGY GENERAL SURGERY ENT LASER AT YOUR SIDE IN YOUR HANDS is a high power holmium laser
Urology An introduction to cut up DR J R GOEPEL
Urology An introduction to cut up DR J R GOEPEL Overview Principles Individual organs Small pieces Partial resections Whole organs Data recording and data sets Principles You are working for the patient
Glossary of Terms Prostate Cancer
Patient Information English Glossary of Terms Prostate Cancer Active surveillance A form of treatment in which the doctor actively monitors the tumour or tumours and their growth, based on a strict visiting
THURSDAY, DECEMBER 13, 2018
THURSDAY, DECEMBER 13, 2018 7:00 am Welcome and Introduction 7:10 am The Hans E. Shapira Lecture Prostate Cancer: A Perspective; the Right Treatment for the Right Patient at the Right Time Peter Scardino,
Minimally Invasive Prostate Surgery Department of Urology, Centro Hospitalar do Porto presents:
Minimally Invasive Prostate Surgery presents: 2014 January 24 th - 25 th LIVE SURGERY & CASE DISCUSSIONS DEPARTMENT OF UROLOGY, CENTRO HOSPITALAR DO PORTO WWW.MI-UROLOGY.COM Dear Colleagues On behalf of
ESOU programme Prostate cancer screening: Why screening programme should not be adopted in > 65 A. Heidenreich, Aachen (DE)
Friday, 17 January 08.30-08.40 Welcome M. Babjuk, Prague (CZ) M. Brausi, Modena (IT) 08.40-09.00 Opening address ESOU programme 09.00-11.00 Prostate cancer I: Screening, diagnosis, staging and treatment
An Undergraduate Syllabus for Urology. Produced on behalf of the British Association of Urological Surgeons. March 2012
An Undergraduate Syllabus for Urology Produced on behalf of the British Association of Urological Surgeons March 2012 Authors H Hashim, P Jones, KJ O Flynn, I Pearce, J Royle, M Shaw, AM Sinclair Correspondence
Prostate Cancer. What is the prostate?
Prostate Cancer Prostate cancer is the third-leading cause of cancer deaths among men in the United States. Yet, when detected in its early stages, prostate cancer can be effectively treated and cured.
Stephen McManus, MD David Levi, MD
Stephen McManus, MD David Levi, MD Prostate MRI Indications INITIAL DETECTION, STAGING, RECURRENT TUMOR LOCALIZATION, RADIATION THERAPY PLANNING INITIAL DETECTION Clinically suspected prostate cancer before
Diagnosis and Classification of Prostate Cancer
Patient Information English 32 Diagnosis and Classification of Prostate Cancer The underlined terms are listed in the glossary. prostate biopsy is the only test that can confirm a prostate cancer diagnosis.
100% Effective Natural Hormone Treatment Menopause, Andropause And Other Hormone Imbalances Impair Healthy Healing In People Over The Age Of 30!
This Free E Book is brought to you by Natural Aging.com. 100% Effective Natural Hormone Treatment Menopause, Andropause And Other Hormone Imbalances Impair Healthy Healing In People Over The Age Of 30!